Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.

ABSTRACT: A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.).

SUBMITTER: Kwan JM 

PROVIDER: S-EPMC8311348 | biostudies-literature |

REPOSITORIES: biostudies-literature